{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:41:43Z","timestamp":1781534503967,"version":"3.54.5"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Limburg Clinical Research Center"},{"DOI":"10.13039\/100022919","name":"Limburgs Kankerfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11764-024-01553-y","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T22:02:21Z","timestamp":1708552941000},"page":"1293-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer therapy\u2013related vaginal toxicity: its prevalence and assessment methods\u2014a systematic review"],"prefix":"10.1007","volume":"19","author":[{"given":"Marith\u00e9","family":"Claes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Robijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Van De Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bulens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mebis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"1553_CR1","unstructured":"W. H. Organisation. Cancer Today 2020 [Available from: https:\/\/gco.iarc.fr\/today\/home. Accessed Sept 2022"},{"issue":"1","key":"1553_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2013an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1200\/JOP.18.00710","volume":"15","author":"TA Sussman","year":"2019","unstructured":"Sussman TA, Kruse ML, Thacker HL, Abraham J. Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy. J Oncol Pract. 2019;15(7):363\u201370.","journal-title":"J Oncol Pract"},{"issue":"8","key":"1553_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/cancers11081125","volume":"11","author":"S Charmsaz","year":"2019","unstructured":"Charmsaz S, Collins DM, Perry AS, Prencipe M. Novel strategies for cancer treatment: highlights from the 55th IACR Annual Conference. Cancers. 2019;11(8):1125.","journal-title":"Cancers"},{"issue":"4","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3747\/co.v15i4.362","volume":"15","author":"C De Angelis","year":"2008","unstructured":"De Angelis C. Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? Curr Oncol. 2008;15(4):198\u20139.","journal-title":"Curr Oncol"},{"issue":"10","key":"1553_CR6","first-page":"2553","volume":"20","author":"E Mazzotti","year":"2012","unstructured":"Mazzotti E, AntoniniCappellini GC, Buconovo S, Morese R, Scoppola A, Sebastiani C, et al. Treatment-related side effects and quality of life in cancer patients. Support Care Cancer. 2012;20(10):2553\u20137.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1471-6712.2012.01085.x","volume":"27","author":"B Pedersen","year":"2013","unstructured":"Pedersen B, Koktved DP, Nielsen LL. Living with side effects from cancer treatment\u2013a challenge to target information. Scand J Caring Sci. 2013;27(3):715\u201323.","journal-title":"Scand J Caring Sci"},{"issue":"4","key":"1553_CR8","first-page":"e7586","volume":"12","author":"K Angelou","year":"2020","unstructured":"Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586.","journal-title":"Cureus"},{"issue":"10","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML, P,. Vulvovaginal Atrophy Terminology Consensus Conference. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063\u20138.","journal-title":"Menopause"},{"issue":"4","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/medicina57040336","volume":"57","author":"G Varyte","year":"2021","unstructured":"Varyte G, Bartkeviciene D. Pelvic radiation therapy induced vaginal stenosis: a review of current modalities and recent treatment advances. Medicina (Kaunas). 2021;57(4):336.","journal-title":"Medicina (Kaunas)"},{"issue":"Suppl 1","key":"1553_CR11","first-page":"55","volume":"5 Suppl 1","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013;5 Suppl 1(Suppl 1):55\u201361.","journal-title":"J Thorac Dis."},{"issue":"6","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/13697137.2019.1606796","volume":"22","author":"SL Bober","year":"2019","unstructured":"Bober SL, Kingsberg SA, Faubion SS. Sexual function after cancer: paying the price of survivorship. Climacteric. 2019;22(6):558\u201364.","journal-title":"Climacteric"},{"issue":"5","key":"1553_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","volume":"36","author":"J Carter","year":"2018","unstructured":"Carter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, et al. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline adaptation of Cancer Care Ontario Guideline. J Clin Oncol. 2018;36(5):492\u2013511.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/GME.0000000000001121","volume":"25","author":"SS Faubion","year":"2018","unstructured":"Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women\u2019s Sexual Health. Menopause. 2018;25(6):596\u2013608.","journal-title":"Menopause"},{"issue":"8","key":"1553_CR15","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s12325-019-01006-4","volume":"36","author":"TM Cerentini","year":"2019","unstructured":"Cerentini TM, Schlottgen J, Viana da Rosa P, La Rosa VL, Vitale SG, Giampaolino P, et al. Clinical and psychological outcomes of the use of vaginal dilators after gynaecological brachytherapy: a randomized clinical trial. Adv Ther. 2019;36(8):1936\u201349.","journal-title":"Adv Ther"},{"issue":"3","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/nau.23931","volume":"38","author":"M Preti","year":"2019","unstructured":"Preti M, Vieira-Baptista P, Digesu GA, Bretschneider CE, Damaser M, Demirkesen O, et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document. Neurourol Urodyn. 2019;38(3):1009\u201323.","journal-title":"Neurourol Urodyn"},{"key":"1553_CR17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2147\/IJWH.S414509","volume":"15","author":"L Cucinella","year":"2023","unstructured":"Cucinella L, Tiranini L, Cassani C, Martella S, Nappi RE. Genitourinary syndrome of menopause in breast cancer survivors: current perspectives on the role of laser therapy. Int J Womens Health. 2023;15:1261\u201382.","journal-title":"Int J Womens Health"},{"issue":"6","key":"1553_CR18","first-page":"2507","volume":"28","author":"N Biglia","year":"2020","unstructured":"Biglia N, Del Pup L, Masetti R, Villa P, Nappi RE. Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi panel. Support Care Cancer. 2020;28(6):2507\u201312.","journal-title":"Support Care Cancer"},{"issue":"7","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman and P. Group","year":"2009","unstructured":"D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman and P. Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"1553_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45.","journal-title":"BMC Med Res Methodol"},{"key":"1553_CR21","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"11","key":"1553_CR22","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2018-01345","volume":"103","author":"SR Davis","year":"2018","unstructured":"Davis SR, Robinson PJ, Jane F, White S, White M, Bell RJ. Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. J Clin Endocrinol Metab. 2018;103(11):4146\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"30","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1200\/JCO.2007.10.8274","volume":"25","author":"SE Jones","year":"2007","unstructured":"Jones SE, Cantrell J, Vukelja S, Pippen J, O\u2019Shaughnessy J, Blum JL, et al. Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy. J Clin Oncol. 2007;25(30):4765\u201371.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1553_CR24","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","volume":"86","author":"MJ Mourits","year":"2002","unstructured":"Mourits MJ, Bockermann I, de Vries EG, van der Zee AG, ten Hoor KA, van der Graaf WT, et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br J Cancer. 2002;86(10):1546\u201350.","journal-title":"Br J Cancer"},{"issue":"4","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000485917","volume":"94","author":"KE Cameron","year":"2018","unstructured":"Cameron KE, Kole MB, Sammel MD, Ginsberg JP, Gosiengfiao Y, Mersereau JE, et al. Acute menopausal symptoms in young cancer survivors immediately following chemotherapy. Oncology. 2018;94(4):200\u20136.","journal-title":"Oncology"},{"issue":"3","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ygyno.2021.10.001","volume":"163","author":"F Gernier","year":"2021","unstructured":"Gernier F, Gompel A, Rousset-Jablonski C, Kalbacher E, Floquet A, Berton-Rigaud D, et al. Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study. Gynecol Oncol. 2021;163(3):598\u2013604.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.3802\/jgo.2017.28.e84","volume":"28","author":"JM Qian","year":"2017","unstructured":"Qian JM, Stahl JM, Young MR, Ratner E, Damast S. Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer. J Gynecol Oncol. 2017;28(6):e84.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.31557\/APJCP.2020.21.2.349","volume":"21","author":"A Shankar","year":"2020","unstructured":"Shankar A, Patil J, Luther A, Mandrelle K, Chakraborty A, Dubey A, et al. Sexual dysfunction in carcinoma cervix: assessment in post treated cases by LENTSOMA scale. Asian Pac J Cancer Prev. 2020;21(2):349\u201354.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijrobp.2014.01.032","volume":"89","author":"K Kirchheiner","year":"2014","unstructured":"Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys. 2014;89(1):88\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1553_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.radonc.2016.04.016","volume":"120","author":"I Ribeiro","year":"2016","unstructured":"Ribeiro I, Janssen H, De Brabandere M, Nulens A, De Bal D, Vergote I, et al. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Radiother Oncol. 2016;120(3):447\u201354.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1553_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pon.3819","volume":"25","author":"VM Boquiren","year":"2016","unstructured":"Boquiren VM, Esplen MJ, Wong J, Toner B, Warner E, Malik N. Sexual functioning in breast cancer survivors experiencing body image disturbance. Psychooncology. 2016;25(1):66\u201376.","journal-title":"Psychooncology"},{"issue":"1","key":"1553_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00340-5","volume":"16","author":"S Chibonda","year":"2021","unstructured":"Chibonda S, Ndlovu N, Tsikai N, Munangaidzwa L, Ndarukwa S, Nyamhunga A, et al. Working title: high dose rate intra-cavitary brachytherapy with cobalt 60 source for locally advanced cervical cancer: the Zimbabwean experience. Infect Agent Cancer. 2021;16(1):1.","journal-title":"Infect Agent Cancer"},{"key":"1553_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13014-015-0551-0","volume":"10","author":"N Cihoric","year":"2015","unstructured":"Cihoric N, Tsikkinis A, Tapia C, Aebersold DM, Zlobec I, Lossl K. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Radiat Oncol. 2015;10:240.","journal-title":"Radiat Oncol"},{"issue":"12","key":"1553_CR34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","volume":"24","author":"ED Cook","year":"2017","unstructured":"Cook ED, Iglehart EI, Baum G, Schover LL, Newman LL. Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause. 2017;24(12):1360\u20134.","journal-title":"Menopause"},{"issue":"6","key":"1553_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.5114\/jcb.2016.64511","volume":"8","author":"C Laliscia","year":"2016","unstructured":"Laliscia C, Delishaj D, Fabrini MG, Gonnelli A, Morganti R, Perrone F, et al. Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit? J Contemp Brachytherapy. 2016;8(6):512\u20137.","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"1553_CR36","first-page":"617","volume":"8","author":"Y Ma","year":"2018","unstructured":"Ma Y, Zhao G, Qi J, Sun P, Liu C, Qu P, et al. Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: a retrospective comparison with chemoirradiation. Mol Clin Oncol. 2018;8(4):617\u201322.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"1553_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0090-8258(86)90216-7","volume":"23","author":"CA Perez","year":"1986","unstructured":"Perez CA, Camel HM, Kuske RR, Kao MS, Galakatos A, Hederman MA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol. 1986;23(2):127\u201340.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"1553_CR38","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1089\/jwh.2010.2308","volume":"20","author":"CA Befort","year":"2011","unstructured":"Befort CA, Klemp J. Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors. J Womens Health. 2011;20(9):1307\u201313.","journal-title":"J Womens Health"},{"issue":"18","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJM199905063401802","volume":"340","author":"K Bergmark","year":"1999","unstructured":"Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340(18):1383\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1553_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C, Flynn C, Dranitsaris G, Bolivar R, et al. Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer. 2009;9(2):108\u201317.","journal-title":"Clin Breast Cancer"},{"issue":"16","key":"1553_CR41","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.7314\/APJCP.2014.15.16.6657","volume":"15","author":"B Demirtas","year":"2014","unstructured":"Demirtas B, Pinar G. Determination of sexual problems of Turkish patients receiving gynecologic cancer treatment: a cross-sectional study. Asian Pac J Cancer Prev. 2014;15(16):6657\u201363.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"1553_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/GME.0000000000001337","volume":"26","author":"CS Dorfman","year":"2019","unstructured":"Dorfman CS, Arthur SS, Kimmick GG, Westbrook KW, Marcom PK, Corbett C, et al. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy. Menopause. 2019;26(8):823\u201332.","journal-title":"Menopause"},{"issue":"6","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/gme.0b013e3181aac32b","volume":"16","author":"T Dorjgochoo","year":"2009","unstructured":"Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study. Menopause. 2009;16(6):1205\u201312.","journal-title":"Menopause"},{"issue":"1","key":"1553_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/0284186X.2020.1813326","volume":"60","author":"M Fogh","year":"2021","unstructured":"Fogh M, Hojgaard A, Rotbol CB, Jensen AB. The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study. Acta Oncol. 2021;60(1):61\u20138.","journal-title":"Acta Oncol"},{"issue":"5","key":"1553_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/annonc\/mdl030","volume":"17","author":"A Glaus","year":"2006","unstructured":"Glaus A, Boehme C, Thurlimann B, Ruhstaller T, Hsu Schmitz SF, Morant R, et al. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol. 2006;17(5):801\u20136.","journal-title":"Ann Oncol."},{"issue":"12","key":"1553_CR46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/annonc\/mdl299","volume":"17","author":"MG Leining","year":"2006","unstructured":"Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol. 2006;17(12):1777\u201382.","journal-title":"Ann Oncol"},{"issue":"3","key":"1553_CR47","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/curroncol29030149","volume":"29","author":"A Moskalewicz","year":"2022","unstructured":"Moskalewicz A, Di Tomaso A, Kachura JJ, Scime S, Nisenbaum R, Lee R, et al. Gynecologic symptoms among hormone receptor-positive breast cancer patients on oral endocrine therapy: a cross-sectional study. Curr Oncol. 2022;29(3):1813\u201327.","journal-title":"Curr Oncol"},{"issue":"1","key":"1553_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09513590.2020.1813273","volume":"37","author":"RE Nappi","year":"2021","unstructured":"Nappi RE, Palacios S, Bruyniks N, Particco M, Panay N, Investigators ES. The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy. Gynecol Endocrinol. 2021;37(1):78\u201382.","journal-title":"Gynecol Endocrinol."},{"issue":"2","key":"1553_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1188\/21.ONF.229-241","volume":"48","author":"Y Sheng","year":"2021","unstructured":"Sheng Y, Carpenter JS, Cohee AA, Storey S, Stump TE, Monahan PO, et al. Genitourinary symptoms in breast cancer survivors: prevalence, correlates, and relationship with sexual functioning. Oncol Nurs Forum. 2021;48(2):229\u201341.","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"1553_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-017-4305-6","volume":"165","author":"C Stabile","year":"2017","unstructured":"Stabile C, Goldfarb S, Baser RE, Goldfrank DJ, Abu-Rustum NR, Barakat RR, et al. Sexual health needs and educational intervention preferences for women with cancer. Breast Cancer Res Treat. 2017;165(1):77\u201384.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1553_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jsxm.2016.05.005","volume":"13","author":"V Sun","year":"2016","unstructured":"Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Herrinton LJ, et al. Sexual function and health-related quality of life in long-term rectal cancer survivors. J Sex Med. 2016;13(7):1071\u20139.","journal-title":"J Sex Med"},{"key":"1553_CR52","doi-asserted-by":"publisher","first-page":"905459","DOI":"10.3389\/fpsyg.2022.905459","volume":"13","author":"R Zhao","year":"2022","unstructured":"Zhao R, Liu H, Gao J. Side effects of endocrine therapy are associated with depression and anxiety in breast cancer patients accepting endocrine therapy: a cross-sectional study in China. Front Psychol. 2022;13:905459.","journal-title":"Front Psychol"},{"issue":"5","key":"1553_CR53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jsxm.2019.03.001","volume":"16","author":"KI Neijenhuijs","year":"2019","unstructured":"Neijenhuijs KI, Hooghiemstra N, Holtmaat K, Aaronson NK, Groenvold M, Holzner B, et al. The Female Sexual Function Index (FSFI)-a systematic review of measurement properties. J Sex Med. 2019;16(5):640\u201360.","journal-title":"J Sex Med"},{"issue":"1","key":"1553_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr. 2021;112(1):90\u20132.","journal-title":"Actas Dermosifiliogr"},{"key":"1553_CR55","doi-asserted-by":"publisher","first-page":"109437","DOI":"10.1016\/j.radonc.2022.109437","volume":"178","author":"J Mejia-Gomez","year":"2023","unstructured":"Mejia-Gomez J, Petrovic I, Doherty M, Kennedy E, Wolfman W, Jacobson M, et al. Sexual dysfunction in female patients with anal cancer treated with curative intent: a systematic review of the literature. Radiother Oncol. 2023;178:109437.","journal-title":"Radiother Oncol"},{"issue":"10","key":"1553_CR56","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/codi.14710","volume":"21","author":"A Thyo","year":"2019","unstructured":"Thyo A, Elfeki H, Laurberg S, Emmertsen KJ. Female sexual problems after treatment for colorectal cancer - a population-based study. Colorectal Dis. 2019;21(10):1130\u20139.","journal-title":"Colorectal Dis"},{"issue":"8","key":"1553_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/medicina55080482","volume":"55","author":"C Secosan","year":"2019","unstructured":"Secosan C, Balint O, Pirtea L, Grigoras D, Balulescu L, Ilina R. Surgically induced menopause-a practical review of literature. Medicina. 2019;55(8):482.","journal-title":"Medicina"},{"issue":"10","key":"1553_CR58","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s00405-020-06164-8","volume":"277","author":"S Gumussoy","year":"2020","unstructured":"Gumussoy S, Gumussoy M, Hortu I, Ergenoglu AM. The effect of surgical menopause after bilateral oophorectomy on hormonal changes, mucociliary clearance, and quality of life. Eur Arch Otorhinolaryngol. 2020;277(10):2793\u2013800.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"1553_CR59","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ecl.2015.05.003","volume":"44","author":"M Rodriguez","year":"2015","unstructured":"Rodriguez M, Shoupe D. Surgical menopause. Endocrinol Metab Clin North Am. 2015;44(3):531\u201342.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1553_CR60","doi-asserted-by":"publisher","first-page":"572388","DOI":"10.3389\/fendo.2020.572388","volume":"11","author":"D Mauri","year":"2020","unstructured":"Mauri D, Gazouli I, Zarkavelis G, Papadaki A, Mavroeidis L, Gkoura S, et al. Chemotherapy associated ovarian failure. Front Endocrinol (Lausanne). 2020;11:572388.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1553_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-319-70197-4_2","volume":"173","author":"R Shah","year":"2018","unstructured":"Shah R, O\u2019Regan RM. Adjuvant endocrine therapy. Cancer Treat Res. 2018;173:15\u201329.","journal-title":"Cancer Treat Res"},{"issue":"7","key":"1553_CR62","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/1878-0261.12690","volume":"14","author":"Y Lievens","year":"2020","unstructured":"Lievens Y, Borras JM, Grau C. Provision and use of radiotherapy in Europe. Mol Oncol. 2020;14(7):1461\u20139.","journal-title":"Mol Oncol"},{"issue":"2","key":"1553_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3747\/co.27.6233","volume":"27","author":"V Dilalla","year":"2020","unstructured":"Dilalla V, Chaput G, Williams T, Sultanem K. Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients. Curr Oncol. 2020;27(2):107\u201312.","journal-title":"Curr Oncol"},{"issue":"4","key":"1553_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000496036","volume":"42","author":"P Delia","year":"2019","unstructured":"Delia P, Sansotta G, Pontoriero A, Iati G, De Salvo S, Pisana M, et al. Clinical evaluation of low-molecular-weight hyaluronic acid-based treatment on onset of acute side effects in women receiving adjuvant radiotherapy after cervical surgery: a randomized clinical trial. Oncol Res Treat. 2019;42(4):217\u201323.","journal-title":"Oncol Res Treat"},{"issue":"2","key":"1553_CR65","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ygyno.2020.11.025","volume":"160","author":"AY Jia","year":"2021","unstructured":"Jia AY, Viswanathan AN. Vaginal necrosis: a rare late toxicity after radiation therapy. Gynecol Oncol. 2021;160(2):602\u20139.","journal-title":"Gynecol Oncol"},{"key":"1553_CR66","unstructured":"Majeed H, Gupta V. Adverse effects of radiation therapy. StatPearls. Treasure Island (FL)2022."},{"issue":"12","key":"1553_CR67","first-page":"885","volume":"31","author":"J Leventhal","year":"2017","unstructured":"Leventhal J, Young MR. Radiation dermatitis: recognition, prevention, and management. Oncology (Williston Park). 2017;31(12):885\u20137, 94-9.","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"1553_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12958-018-0432-0","volume":"16","author":"R Marci","year":"2018","unstructured":"Marci R, Mallozzi M, Di Benedetto L, Schimberni M, Mossa S, Soave I, et al. Radiations and female fertility. Reprod Biol Endocrinol. 2018;16(1):112.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1553_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13104-022-05970-z","volume":"15","author":"S Yap","year":"2022","unstructured":"Yap S, Vassallo A, Goldsbury DE, Salagame U, Velentzis L, Banks E, et al. Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause. BMC Res Notes. 2022;15(1):88.","journal-title":"BMC Res Notes"},{"issue":"8","key":"1553_CR70","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","volume":"33","author":"M Di Maio","year":"2015","unstructured":"Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910\u20135.","journal-title":"J Clin Oncol"},{"issue":"23","key":"1553_CR71","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"1553_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1477-7525-8-104","volume":"8","author":"EA Laugsand","year":"2010","unstructured":"Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"1553_CR73","first-page":"2633","volume":"23","author":"I Bartula","year":"2015","unstructured":"Bartula I, Sherman KA. The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Support Care Cancer. 2015;23(9):2633\u201341.","journal-title":"Support Care Cancer"},{"issue":"6","key":"1553_CR74","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1046\/j.1464-410X.1996.00186.x","volume":"77","author":"S Jackson","year":"1996","unstructured":"Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77(6):805\u201312.","journal-title":"Br J Urol"},{"issue":"3","key":"1553_CR75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/gme.0b013e3181ef975a","volume":"18","author":"JV Radtke","year":"2011","unstructured":"Radtke JV, Terhorst L, Cohen SM. The Menopause-Specific Quality of Life Questionnaire: psychometric evaluation among breast cancer survivors. Menopause. 2011;18(3):289\u201395.","journal-title":"Menopause"},{"issue":"2","key":"1553_CR76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat. 1999;55(2):189\u201399.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1553_CR77","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.breast.2004.02.009","volume":"13","author":"KM Malinovszky","year":"2004","unstructured":"Malinovszky KM, Cameron D, Douglas S, Love C, Leonard T, Dixon JM, et al. Breast cancer patients\u2019 experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET). Breast. 2004;13(5):363\u20138.","journal-title":"Breast"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01553-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:21:02Z","timestamp":1757118062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01553-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01553-y","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}